| 000 | 01813 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513225539.0 | ||
| 264 | 0 | _c20010208 | |
| 008 | 200102s 0 0 eng d | ||
| 022 | _a0959-4973 | ||
| 024 | 7 |
_a10.1097/00001813-200010000-00003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeerum Terwogt, J | |
| 245 | 0 | 0 |
_aCremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol) and carboplatin in non-small cell lung cancer patients. _h[electronic resource] |
| 260 |
_bAnti-cancer drugs _cOct 2000 |
||
| 300 |
_a687-94 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacokinetics |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycerol _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aPharmaceutical Vehicles _xadministration & dosage |
| 700 | 1 | _avan Tellingen, O | |
| 700 | 1 | _aNannan Panday, V R | |
| 700 | 1 | _aHuizing, M T | |
| 700 | 1 | _aSchellens, J H | |
| 700 | 1 | _aten Bokkel Huinink, W W | |
| 700 | 1 | _aBoschma, M U | |
| 700 | 1 | _aGiaccone, G | |
| 700 | 1 | _aVeenhof, C H | |
| 700 | 1 | _aBeijnen, J H | |
| 773 | 0 |
_tAnti-cancer drugs _gvol. 11 _gno. 9 _gp. 687-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00001813-200010000-00003 _zAvailable from publisher's website |
| 999 |
_c11070114 _d11070114 |
||